Anticancer agent 73
|
化合物 ANTICANCER AGENT 73
|
124811-87-6
|
NLRP3/AIM2-IN-2
|
化合物 NLRP3/AIM2-IN-2
|
791840-86-3
|
Sotuletinib hydrochloride
|
BLZ945鹽酸鹽
|
2222138-31-8
|
Regaloside B
|
4-amino-N-[4-(trifluoromethyl)phenyl]benzamide
|
1011244-72-6
|
Mirin
|
(5E)-5-(4-HYDROXYBENZYLIDENE)-2-IMINO-1,3-THIAZOLIDIN-4-ONE
|
299953-00-7
|
Enfuvirtide acetate
|
4]苯并二氮雜卓-4-乙酰胺
|
914454-00-5
|
Tivozanib hydrochloride hydrate
|
N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(5-甲基-3-異惡唑基)脲
|
682745-41-1
|
Tau tracer 2
|
((S)-1 - ((S)-1 - (((3R,4S,5S)-1 - ((S)-2 - ((1R,2
|
474645-26-6
|
Velusetrag hydrochloride
|
Velusetrag hydrochloride
|
866933-51-9
|
BV02
|
2-(1,5-DIMETHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOL-4-YL)-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID
|
292870-53-2
|
Primaquine
|
伯氨喹
|
90-34-6
|
BAY-4931
|
BAY-4931
|
423150-91-8
|
Luciferase-IN-1
|
(4-Benzothiazol-2-yl-phenyl)-dimethyl-amine
|
10205-56-8
|
LP-261
|
LP-261
|
915412-67-8
|
Verapamil-d
|
N-(6-Nitrobenzo[d]thiazol-2-yl) cyclohexane carboxaMide
|
312747-21-0
|
Cefepime
|
頭孢吡肟
|
88040-23-7
|
Bisantrene dihydrochloride
|
比生群二鹽酸鹽
|
71439-68-4
|
POT-4
|
AC-ILE-CYS-VAL-TRP(ME)-GLN-ASP-TRP-GLY-ALA-HIS-ARG-CYS-THR-NH2
|
934461-40-2
|
Arteannuin B
|
化合物 84-B10
|
698346-43-9
|
SRI-41315
|
2-環(huán)丁基-10-甲基-3-苯基嘧啶并[4,5-B]喹啉-4,5(3H,10H)-二酮
|
1613509-49-1
|
Enoxaparin
|
依諾肝素鈉
|
679809-58-6
|
TP0472993
|
化合物CYP4A11/CYP4F2-IN-2
|
2126874-77-7
|
BMS-309403 sodium
|
BMS-309403 SODIUM
|
2802523-05-1
|
Isovalerylcarnitine chloride
|
L-異戊?;鈮A
|
139144-12-0
|
Aderbasib
|
(6S,7S)-7-[(羥基氨基)甲酰基]-6-[(4-苯基-1-哌嗪基)甲?;鵠-5-氮雜螺[2.5]辛烷-5-甲酸甲酯
|
791828-58-5
|
GPR41 agonist-1
|
化合物 GPR41 AGONIST-1
|
506417-09-0
|
SCFSkp2-IN-2
|
化合物SCFSKP2-IN-2
|
1375060-02-8
|
HSD-016
|
HSD-016
|
946396-92-5
|
L-Leucinol
|
L-亮氨醇
|
7533-40-6
|
MSP-3
|
2-Thiophenebutanamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-
|
1820968-63-5
|
sEH inhibitor-7
|
化合物 SEH INHIBITOR-7
|
340221-20-7
|
PA3552-IN-1
|
化合物 PA3552-IN-1
|
1008121-12-7
|
ERCC1-XPF-IN-2
|
化合物ERCC1-XPF-IN-2
|
1808986-37-9
|
BAY-0069
|
BAY-0069
|
420826-65-9
|
Anti-inflammatory agent 35
|
化合物T64358
|
2293951-00-3
|
Fozivudine tidoxil
|
5'-O-[二(4-甲氧基苯基)苯基甲基]-2'-脫氧-N-(苯氧基乙?;?-腺苷 3'-[2-氰基乙基 二異丙基亞磷酰胺]
|
110543-74-3
|
FAK-IN-7
|
N-(5-(對甲苯基)-1,3,4-噻二唑-2-基)苯甲酰胺
|
19948-85-7
|
2'-F-Bz-dC Phosphoramidite
|
N4-苯甲?;?5'-O-DMT-2'-氟-脫氧胞苷-3'-氰乙氧基亞磷酰胺
|
161442-19-9
|
NMDAR/TRPM4-IN-2 free base
|
N'-[(3-溴苯基)甲基]-N'-乙基乙烷-1,2-二胺
|
1353979-43-7
|
PND-1186 hydrochloride
|
CS-1120
|
1356154-94-3
|
ABT-384
|
ABT-384 ; ABT 384 ; ABT384 ;
|
868623-40-9
|
Enpp/Carbonic anhydrase-IN-1
|
4-(金剛烷-1-甲酰胺基)苯基 苯磺酸酯
|
2883495-35-8
|
PR-104
|
PR-104/104A
|
851627-62-8
|
EAI001
|
2-(1-氧代異吲哚啉-2-基)-2-苯基-N-(噻唑-2-基)乙酰胺
|
892772-75-7
|
Dlin-MeOH
|
(6Z,9Z,28Z,31Z)-三十七烷-6,9,28,31-四烯-19-醇
|
1169768-28-8
|
α-Methyltyrosine methyl ester hydrochloride
|
Α-甲基-DL-酪氨酸甲酯鹽酸鹽
|
7361-31-1
|
NFAT Inhibitor-2
|
4-Fluoro-n-(3-fluoro-4-methylphenyl)-3-([(4-methoxyphenyl)methyl]sulfamoyl)benzamide
|
422546-87-0
|
GSK2879552 dihydrochloride
|
GSK2879552
|
1902123-72-1
|
MPO-IN-3
|
MPO-IN-3
|
1435469-45-6
|
ALDH1A3-IN-1
|
化合物 ALDH1A3-IN-1
|
1695970-90-1
|
Andolast free base
|
4-(1H-tetrazol-5-yl)-N-(4-(1H-tetrazol-5-yl)phenyl)benzamide
|
132640-22-3
|
4'-Hydroxyflavanone
|
4'-羥基黃烷酮
|
6515-37-3
|
L82
|
化合物 L82
|
329227-30-7
|
SRI-37240
|
化合物 SRI-37240
|
883956-47-6
|
KKII5
|
4,6-二苯基-1,2,3,4-四氰嘧啶-2-硫
|
6381-55-1
|
Acetaminophen glucuronide
|
奧西替尼雜質(zhì)2
|
2227103-37-7
|
MIF-1 TFA
|
MIF-1 TFA
|
35240-69-8
|
Bicuculline methiodide
|
(-)-荷苞牡丹堿
|
40709-69-1
|
YSK 05
|
YSK05
|
1318793-78-0
|
Mevalonic acid lithium salt
|
MEVALONATE (LITHIUM SALT)
|
2618458-93-6
|
PKA-IN-1
|
1-ACETAMIDO-4-CYANO-3-METHYLISOQUINOLINE
|
179985-52-5
|
Avanbulin
|
BAL27862
|
798577-91-0
|
ASN03576800
|
ASN03576800
|
957513-35-8
|
Chiglitazar
|
CHIGLITAZAR
|
743438-45-1
|
AZT triphosphate TEA
|
3',4'-二甲氧基黃酮
|
4143-62-8
|
SW157765
|
3-(呋喃-2-基)-N-(2-(吡啶-4-基)苯并[D]惡唑-5-基)丙烯酰胺
|
332063-87-3
|
L-Phenylalanine-d
|
氘代L-苯丙氨酸
|
56253-90-8
|
AZD8848
|
methyl 2-[3-({[3-(6-amino-2-butoxy-8-oxo-8,9-dihydro-7H-purin-9-yl)propyl][3-(morpholin-4-yl)propyl]amino}methyl)phenyl]acetate
|
866269-28-5
|
YZ129
|
YZ129
|
1643120-60-8
|
Triperiden
|
TRIPERIDEN
|
14617-17-5
|
SCH 32615
|
SCH 32615
|
83861-02-3
|
AZD1656
|
AZD1656
|
919783-22-5
|
1,2-Dioleoyl-sn-glycero-3-phospho-L-serine sodium
|
1,2-二-(9Z-十八碳烯酰基)-sn-甘油-3-磷酰-L-絲氨酸鈉鹽
|
90693-88-2
|
Sodium pyrophosphate
|
焦磷酸二氫二鈉
|
7758-16-9
|
L-Leucine-
|
L-亮氨酸-1-13C
|
74292-94-7
|
Protamine sulfate
|
原兒茶醛
|
9009-65-8
|
PD 151746
|
|
181765-30-0
|
NCT02
|
2-{5H,6H,7H-茚并[5,6-B]呋喃-3-基}-N-(5-甲基-1,3-噻唑-2-基)乙酰胺
|
790245-61-3
|
STL1267
|
化合物 STL1267
|
1429024-58-7
|
SIRT1 activator 3
|
WAY-272277
|
708995-11-3
|
LP-922056
|
LX5061
|
1365060-22-5
|
KCNQ2/3 activator-1
|
N-[4-(6-氟-3,4-二氫-2(1H)-異喹啉基)-2,6-二甲基苯基]-3,3-二甲基丁酰胺
|
1009344-33-5
|
Aniracetam
|
化合物 BRADANICLINE
|
639489-84-2
|
1,2-Distearoyl-sn-Glycero-3-Phosphatidylglycerol sodium
|
二硬脂酰磷脂酰甘油 鈉鹽
|
200880-42-8
|
ML291
|
ML291
|
1523437-16-2
|
Deferoxamine
|
去鐵胺
|
70-51-9
|
BI-9627 hydrochloride
|
BIX HCl
|
1422252-46-7
|
ML-SA5
|
N'-[3-氯-2-(1-哌啶基)苯基]-N,N-二甲基-1,4-苯二磺酰胺
|
2418670-70-7
|
SLF TFA
|
|
2378802-47-0
|
DSPE-Mal
|
DSPE-馬來酰亞胺
|
1360858-99-6
|
NT1-014B
|
NT1-O14B
|
2739805-64-0
|
Mtb ATP synthase-IN-1
|
化合物 MTB ATP SYNTHASE-IN-1
|
2642394-38-3
|
LDC4297 hydrochloride
|
化合物 LDC4297 HYDROCHLORIDE
|
2319747-14-1
|
(Z)-Orantinib
|
SU 6668
|
210644-62-5
|
EGFR-IN-51
|
2-(ACETYLOXY)-4-[(NITROOXY)METHYL]PHENYL ESTER, BENZOIC ACID
|
287118-97-2
|
Clavulanic acid
|
克拉維酸
|
58001-44-8
|
Thiamine disulfide
|
二硫化硫胺
|
67-16-3
|
Tetracaine
|
丁卡因
|
94-24-6
|
Valiloxibic acid
|
VALILOXIBIC ACID
|
238401-16-6
|
GKT136901 hydrochloride
|
GKT136901 HYDROCHLORIDE
|
1254507-01-1
|